| 110.38 Delayed Data As of Nov 12 |  +0.34 / +0.31%Today’s Change | 89.01 Today|||52-Week Range 116.25 | +14.47% Year-to-Date |
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
| 1 month | +9.64% | 3 years | +4.88% | |
| 3 months | +4.40% | 5 years | +2.37% | |
| 1 year | +2.25% | Since inception | +6.73% |
| Previous close | $110.04 |
| Open day’s range | 109.82 – 111.33 |
| Net asset value (NAV) | 109.98 (11/11/2019) |
| Daily volume | 2,516,855 |
| Average volume (3 months) | 2,352,113 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +2.37% | +7.05% |
| Expense Gross exp ratio | 0.47% | 1.24% |
| Risk 5 year sharpe ratio | 0.15 | 0.44 |
| Net assets | $6.9B | $3.1B |
| Average market cap | $14.8B | $34.6B |
| Average P/E | 18.3 | 23.8 |
| Dividend / Share | -- | 0.26% |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| IXJ iShares Global Healthcare ETF |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| CELG Celgene | 8.56% |
| AMGN Amgen | 7.84% |
| GILD Gilead Sciences | 7.69% |
| VRTX Vertex Pharmaceuticals Inc | 6.70% |
| ILMN Illumina Inc | 5.79% |
| BIIB Biogen | 5.22% |
| REGN Regeneron Pharmaceuticals | 4.05% |
| ALXN Alexion Pharmaceuticals Inc | 3.27% |
| SGEN Seattle Genetics Inc | 2.53% |
| INCY Incyte Corp | 2.50% |
